Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0285714285714286 -0.035164835164835 -0.0768791208791207 -0.0580219780219779
Stock impact report

Endocyte up another 7% as Cowen upgrades [Seeking Alpha]

ENDOCYTE (ECYT) 
Last endocyte earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.endocyte.com/investor-relations
Company Research Source: Seeking Alpha
Endocyte up another 7% as Cowen upgradesThe risk/reward at the current stock valuation looks good, says analyst Boris Peaker, noting PSMA-617 has been tested in 2K-3K patients in Germany and the feedback from one doctor has been very positive.He conservatively sees the drug launching in 2022.Then there's the CAR-T program, which Peaker calls a "free lottery ticket" as it's not yet factored into the current share price.He upgrades to Outperform.Source: BloombergECYT+7% premarketPreviously:Endocyte readies late-stage study of Lu-PSMA-617 in prostate cancer; shares up 7% (Feb. 26)See all stocks on the move »Now read:Rigel Is A Buy For Its First NDA » Show less Read more
Impact Snapshot
Event Time:
ECYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ECYT alerts
Opt-in for
ECYT alerts

from News Quantified
Opt-in for
ECYT alerts

from News Quantified